ArTS Archivio della ricerca di Trieste

MARZARI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.472
EU - Europa 2.409
AS - Asia 845
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 7
AF - Africa 3
OC - Oceania 1
Totale 10.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.455
UA - Ucraina 640
SE - Svezia 595
IT - Italia 374
CN - Cina 313
FI - Finlandia 224
HK - Hong Kong 180
SG - Singapore 180
TR - Turchia 140
GB - Regno Unito 125
DE - Germania 107
BG - Bulgaria 95
IE - Irlanda 94
FR - Francia 61
BE - Belgio 27
CH - Svizzera 22
CA - Canada 17
EU - Europa 15
IN - India 10
NL - Olanda 10
RU - Federazione Russa 10
CZ - Repubblica Ceca 9
KR - Corea 8
JP - Giappone 6
BR - Brasile 5
MY - Malesia 3
RO - Romania 3
SN - Senegal 3
GR - Grecia 2
NO - Norvegia 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
Totale 10.753
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.043
Ann Arbor 1.014
Houston 872
Fairfield 829
Jacksonville 552
Chandler 494
Ashburn 473
Wilmington 408
Seattle 336
Cambridge 274
Princeton 190
Hong Kong 180
Izmir 138
Singapore 136
Beijing 102
Sofia 95
Dublin 93
Boardman 90
Trieste 71
Milan 64
Dearborn 61
Bremen 45
Düsseldorf 42
San Diego 38
Helsinki 36
Santa Clara 36
Falls Church 30
Brussels 25
Chicago 25
Verona 22
Jinan 20
Bern 19
Sacile 19
Des Moines 18
Nanjing 18
Buffalo 17
Guangzhou 17
Norwalk 16
Toronto 12
Hefei 10
Kunming 10
Mestre 10
Andover 8
Auburn Hills 8
Brno 8
Columbus 8
Fremont 8
Phoenix 8
Shenyang 8
Washington 8
Redwood City 7
Cascina 6
London 6
Pune 6
Seoul 6
Shanghai 6
Chongqing 5
Grafing 5
Hangzhou 5
Los Angeles 5
Rome 5
Tokyo 5
Fuzhou 4
Hebei 4
Munich 4
San Francisco 4
Taizhou 4
Udine 4
Dakar 3
Detroit 3
Groningen 3
Indiana 3
Moscow 3
Nanchang 3
Ottawa 3
São Paulo 3
Tianjin 3
Wuhan 3
Chengdu 2
Dallas 2
Dongjak-gu 2
Edinburgh 2
Kocaeli 2
Kuala Lumpur 2
Leawood 2
Leipzig 2
Mantova 2
Maribor 2
Montreal 2
Paris 2
San Mateo 2
Shaoxing 2
Taiyuan 2
Torre Del Greco 2
Treviso 2
Utrecht 2
Zhengzhou 2
Zurich 2
Amsterdam 1
Antwerpen 1
Totale 8.227
Salva come PNG Salva come JPEG
Nome #
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 215
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 212
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. 203
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 199
Anti-transglutaminase antibodies and age. 192
Autoantibodies as predictors of disease. 191
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 181
The gut as site of production of autoimmune antibodies. 179
Anti transglutaminase antibodies cause ataxia in mice. 176
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 174
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 165
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 163
null 163
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 160
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 160
Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of human high mobility group I-C protein 159
A reliable screening procedure for coeliac disease in clinical practice. 157
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 154
Dual sugar gut-permeability testing on blood drop in animal models. 150
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 149
Development of a novel rapid non-invasive screening test for coeliac disease. 143
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 142
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 142
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 142
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 141
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 139
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 137
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 134
Gluten ataxia: passive transfer in a mouse model. 131
Antibodies in proteomics I: generating antibodies 130
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 127
Anti-idiotypic response in mice expressing human autoantibodies. 127
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 126
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 126
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 125
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 124
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 119
null 119
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 119
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 118
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 115
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. 112
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 111
Profiling celiac disease antibody repertoire 111
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 107
Patterning of fibronectin using laser writer for force measurement in cells 106
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 106
Protective role of anti-idiotypic network in celiac disease prone subjects 105
Anti-transglutaminase and age, Clinical Chemestry 104
Phage display of Bacillus thuringiensis CryIA(a) insecticidal protein 103
A method for selecting phage display open reading frames on phages 100
null 100
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 100
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 99
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 99
Protective role of anti-idiotypic network in celiac disease prone subjects 99
Immunochemical characterisation of a murine monoclonal anti-idiotypic antibody 99
Simple scale-up of recombinant antibody production using an UCOE containing vector 98
null 97
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 97
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 97
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 97
Anti-alpha enolase autoantibodies in coeliac disease 96
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 96
Expression of a cloned Bacillus thuringiensis delta-endotoxin gene in Bacillus subtilis 94
RECOMBINANT ANTIBODIES AGAINST CD55 AND CD59 AND USES THEREOF 93
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 91
Protective role of anti-idiotypic network in celiac disease prone subjects 91
“Impianto di cellule epiteliali amniotiche umane crioconservate in un soggetto affetto da malattia di Niemann-Pick tipo B.” 89
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 88
Human monoclonal anti-transglutaminase antibodies from celiac patients inhibit cell induced apoptosis 87
Serum immunoglobulin A and G, and monoclonal antibodies anti-tissue transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ 86
Antibodies anti-c5 component of the complement system and their use 83
Identification of new antigen candidate of Multiple Sclerosis using an ORF selected phage display library 83
A rat atlas to characterise anti brain humoral resoponse in patients with gluten sensitivity and celiac disease 82
"Recombinant antibodies against human type ii transglutaminase and uses thereof" 81
Small, antibacterial and large, inactive peptides of neutrophil granules share immunoreactivity to a monoclonal antibody. 81
Rapid characterization of VH-5 family specific anti-tTG intestinal antibodies in celiac and autoimmune patients 80
J Pediatr Gastroenterol Nutr 1990 Oct;11(3):337-41 A dot immunobinding assay to detect anti-alpha-gliadin antibodies in celiac disease. 79
Human tissue transglutaminase ELISA: a powerful mass screening diagnostic assay for symptomatic and asymptomatic celiac disease. 72
Malattia celiaca: tra passato e futuro 71
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ 70
Creation of a mouse model of coeliac disease by in vivo long term expression of disease specific anti trasnglutaminase antibody 69
Intestinal mucosa anti-transglutaminase antibodies in early stage of gluten intolerance 69
Coeliac disease risk in patients with idiopathic dilated cardiomiopathy 69
Salivary anti-human transglutaminase in the diagnosis of coeliac disease 68
Filtering out open reading frames 64
Correlation between anti-transglutaminase antibodies and healthy status in the general population 64
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 63
Phage antibody library from celiac disease patient. 58
Identification of novel celiac disease autoantigens by combined phage display and protein array technology 58
Monoclonal anti-transglutaminase antibodies from celiac disease patients inhibit cell-induced apoptosis 58
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet 57
Oral mucosa precedes the intestine on the gluten-dependent immune response 51
Antibodies in proteomics 38
Predicting antigenic peptides suitable for the selection of phage antibodies 20
Molecular dissection of the tissue transglutaminase antoantibody response in celiac disease 20
Selecting Open Reading Frames from DNA 20
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies 11
Rapid interactome profiling by massive sequencing 9
Totale 10.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.847 0 0 99 383 132 287 218 268 177 89 141 53
2020/20211.433 135 83 200 170 80 175 49 126 57 170 49 139
2021/20221.057 38 71 36 113 47 101 45 37 122 103 92 252
2022/20231.484 167 199 112 212 172 272 2 113 159 8 51 17
2023/2024770 50 61 41 76 83 70 114 145 8 7 56 59
2024/2025225 15 60 150 0 0 0 0 0 0 0 0 0
Totale 10.934